Royalty Pharma Executive Sells Shares Under Pre-Arranged Plan
Christopher Hite, Executive Vice President and Chairman of Partnering at Royalty Pharma plc (NASDAQ:RPRX), executed a series of share sales totaling $8,159,276 on June 23, 2026. The transactions, conducted under a pre-arranged 10b5-1 trading plan, involved the disposal of 150,000 Class A Ordinary Shares at prices between $53.39 and $54.94. This act…